Elucidating the precise pharmacological mechanism of action (MOA) of naturally happening compounds can be complicated. Even though Tarselli et al. (sixty) created the initial de novo artificial pathway to conolidine and showcased this naturally transpiring compound efficiently suppresses responses to both equally chemically induced and inflammation